KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 119 filers reported holding KURA ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,036,000 | +6.6% | 62,331 | 0.0% | 0.50% | -11.7% |
| Q3 2020 | $1,910,000 | +88.0% | 62,331 | 0.0% | 0.57% | +67.0% |
| Q2 2020 | $1,016,000 | -27.4% | 62,331 | -55.7% | 0.34% | -42.3% |
| Q1 2020 | $1,400,000 | -23.1% | 140,705 | +6.3% | 0.59% | -8.3% |
| Q4 2019 | $1,820,000 | +0.9% | 132,344 | +8.2% | 0.64% | -6.7% |
| Q3 2019 | $1,804,000 | -10.8% | 122,273 | +19.6% | 0.69% | -7.3% |
| Q2 2019 | $2,022,000 | +9.8% | 102,198 | -25.3% | 0.74% | -9.2% |
| Q1 2019 | $1,841,000 | 0.0% | 136,767 | 0.0% | 0.82% | +3.7% |
| Q4 2018 | $1,841,000 | +9.5% | 136,767 | +41.9% | 0.79% | +36.4% |
| Q3 2018 | $1,681,000 | +0.8% | 96,352 | 0.0% | 0.58% | -6.3% |
| Q2 2018 | $1,667,000 | +11.5% | 96,352 | +20.8% | 0.62% | +0.2% |
| Q1 2018 | $1,495,000 | – | 79,752 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |